T8RP Stock Overview
Indiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Indiva Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.024 |
| 52 Week High | CA$0.048 |
| 52 Week Low | CA$0.007 |
| Beta | 1.1 |
| 1 Month Change | -17.24% |
| 3 Month Change | -30.43% |
| 1 Year Change | -42.86% |
| 3 Year Change | -91.11% |
| 5 Year Change | n/a |
| Change since IPO | -96.84% |
Recent News & Updates
Recent updates
Shareholder Returns
| T8RP | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 17.1% | 2.3% | 0.5% |
| 1Y | -42.9% | -28.6% | 1.3% |
Return vs Industry: T8RP underperformed the German Pharmaceuticals industry which returned -28.2% over the past year.
Return vs Market: T8RP underperformed the German Market which returned 2.3% over the past year.
Price Volatility
| T8RP volatility | |
|---|---|
| T8RP Average Weekly Movement | 17.5% |
| Pharmaceuticals Industry Average Movement | 6.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: T8RP's share price has been volatile over the past 3 months.
Volatility Over Time: T8RP's weekly volatility has decreased from 29% to 18% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Niel Marotta | www.indiva.com |
Indiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada. It offers pre-rolls, flower, capsules, and edible and extract products under the INDIVA, Indiva Life, and Artisan Batch brands. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Jewels Chewable Tarts, Grön edibles, and Dime Industries vape products through license agreements and partnerships.
Indiva Limited Fundamentals Summary
| T8RP fundamental statistics | |
|---|---|
| Market cap | €9.34m |
| Earnings (TTM) | -€4.74m |
| Revenue (TTM) | €24.57m |
0.4x
P/S Ratio-2.1x
P/E RatioIs T8RP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| T8RP income statement (TTM) | |
|---|---|
| Revenue | CA$36.01m |
| Cost of Revenue | CA$26.90m |
| Gross Profit | CA$9.11m |
| Other Expenses | CA$16.05m |
| Earnings | -CA$6.94m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.036 |
| Gross Margin | 25.29% |
| Net Profit Margin | -19.27% |
| Debt/Equity Ratio | 5,776.7% |
How did T8RP perform over the long term?
See historical performance and comparison